BR112020021341A2 - Formulação vaporizável, processo para formar um vapor, sistema eletrônico de provisão de vapor, uso de um agente - Google Patents

Formulação vaporizável, processo para formar um vapor, sistema eletrônico de provisão de vapor, uso de um agente Download PDF

Info

Publication number
BR112020021341A2
BR112020021341A2 BR112020021341-1A BR112020021341A BR112020021341A2 BR 112020021341 A2 BR112020021341 A2 BR 112020021341A2 BR 112020021341 A BR112020021341 A BR 112020021341A BR 112020021341 A2 BR112020021341 A2 BR 112020021341A2
Authority
BR
Brazil
Prior art keywords
weight
cooling agent
formulation
present
amount
Prior art date
Application number
BR112020021341-1A
Other languages
English (en)
Portuguese (pt)
Inventor
Klaus Mathie
Maria Montserrat Sanchez PENA
Original Assignee
Nicoventures Trading Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicoventures Trading Limited filed Critical Nicoventures Trading Limited
Publication of BR112020021341A2 publication Critical patent/BR112020021341A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
    • A24B15/241—Extraction of specific substances
    • A24B15/243—Nicotine
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/281—Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/32—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by acyclic compounds
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/34—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a carbocyclic ring other than a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/36—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring
    • A24B15/38—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/36—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring
    • A24B15/40—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms
    • A24B15/403—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms having only oxygen as hetero atoms
    • A24B15/406—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms having only oxygen as hetero atoms in a five-membered ring
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/10—Devices using liquid inhalable precursors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/006—Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Addiction (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR112020021341-1A 2018-05-03 2019-05-03 Formulação vaporizável, processo para formar um vapor, sistema eletrônico de provisão de vapor, uso de um agente BR112020021341A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1807305.6 2018-05-03
GBGB1807305.6A GB201807305D0 (en) 2018-05-03 2018-05-03 Vaporisable formulation
PCT/GB2019/051244 WO2019211629A1 (en) 2018-05-03 2019-05-03 Vaporisable formulation

Publications (1)

Publication Number Publication Date
BR112020021341A2 true BR112020021341A2 (pt) 2021-01-19

Family

ID=62598261

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112020021341-1A BR112020021341A2 (pt) 2018-05-03 2019-05-03 Formulação vaporizável, processo para formar um vapor, sistema eletrônico de provisão de vapor, uso de um agente

Country Status (13)

Country Link
US (1) US20210368850A1 (enExample)
EP (1) EP3787429A1 (enExample)
JP (2) JP7258911B2 (enExample)
KR (2) KR20230151065A (enExample)
CN (1) CN112074201A (enExample)
AU (2) AU2019264022A1 (enExample)
BR (1) BR112020021341A2 (enExample)
CA (2) CA3190409A1 (enExample)
GB (1) GB201807305D0 (enExample)
IL (2) IL277973B2 (enExample)
MX (1) MX2020011664A (enExample)
MY (1) MY203314A (enExample)
WO (1) WO2019211629A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12588700B2 (en) 2019-12-02 2026-03-31 Jt International Sa E-liquid composition comprising 1,3-propanediol below 50% by weight of the composition
GB202006633D0 (en) * 2020-05-05 2020-06-17 Nicoventures Holdings Ltd Aerosol generating material
US11771136B2 (en) 2020-09-28 2023-10-03 Rai Strategic Holdings, Inc. Aerosol delivery device
GB202110541D0 (en) * 2021-07-22 2021-09-08 Nicoventures Trading Ltd Delivery system
CA3242529A1 (en) * 2022-01-14 2023-07-20 Nicoventures Trading Limited Aerosolisable material

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5097886A (enExample) * 1973-12-28 1975-08-04
JP2005512554A (ja) * 2001-12-19 2005-05-12 ベクター・タバコ・インコーポレーテッド タバコ製品に清涼効果を付与する方法および組成物
US6897195B2 (en) * 2002-07-24 2005-05-24 Nanjing Zhongshi Chemical Co. Composition of menthol and menthyl lactate, its preparation method and its applications as a cooling agent
CA2592635C (en) * 2004-12-29 2013-02-12 Wm. Wrigley Jr. Company Combinations of cooling agents for use in confections
WO2007041035A2 (en) 2005-09-30 2007-04-12 Wm. Wrigley Jr. Company Oral composition and method for stress reduction associated with smoking cessation
WO2007089652A2 (en) * 2006-01-27 2007-08-09 Cadbury Adams Usa Llc Flavor-enhancing compositions, methods of manufacture, and methods of use
US20100056636A1 (en) 2006-12-20 2010-03-04 Stefan Michael Furrer N-Substituted-P-Menthane-3-Carboxamide and Uses Thereof
JP2009148233A (ja) 2007-12-21 2009-07-09 Japan Tobacco Inc 喫煙物品
WO2009140783A1 (en) * 2008-05-22 2009-11-26 Givaudan Sa Cooling composition
DE102010002558A1 (de) * 2009-11-20 2011-06-01 Symrise Ag Verwendung physiologischer Kühlwirkstoffe und Mittel enthaltend solche Wirkstoffe
ES2377785B2 (es) 2010-09-08 2012-09-26 Universidad Miguel Hernández De Elche Composición farmacéutica para el tratamiento del ojo seco.
US9854839B2 (en) * 2012-01-31 2018-01-02 Altria Client Services Llc Electronic vaping device and method
KR102705152B1 (ko) * 2013-05-06 2024-09-09 쥴 랩스, 인크. 에어로졸 장치를 위한 니코틴 염 제제 및 그 방법
US20160128944A1 (en) * 2013-06-04 2016-05-12 Vyome Biosciences Pvt. Ltd. Coated particles and compositions comprising same
US9877511B2 (en) * 2013-07-24 2018-01-30 Altria Client Services Llc Electronic smoking article
US20150313275A1 (en) * 2014-04-30 2015-11-05 Altria Client Services, Inc. Liquid aerosol formulation of an electronic smoking article
JP6061900B2 (ja) 2014-07-24 2017-01-18 長谷川香料株式会社 Ｗｓ−１２の微粒子およびこれを含有する冷感剤組成物
TWI693031B (zh) 2015-04-30 2020-05-11 瑞士商菲利浦莫里斯製品股份有限公司 包含具高通氣度之可卸式清新劑遞送元件的氣溶膠產生物件
GB2544468A (en) * 2015-11-12 2017-05-24 Jaytee Biosciences Ltd Liquid formulation
US20170172204A1 (en) * 2015-12-18 2017-06-22 Altria Client Services Llc Strength enhancers and method of achieving strength enhancement in an electronic vapor device
US20160376263A1 (en) * 2016-07-26 2016-12-29 Senomyx, Inc. Bitter taste modifiers including substituted 1-benzyl-3-(1-(isoxazol-4-ylmethyl)-1h-pyrazol-4-yl)imidazolidine-2,4-diones and compositions thereof
JP6770864B2 (ja) 2016-09-30 2020-10-21 アース製薬株式会社 スプレー型芳香剤
CN106962971A (zh) 2017-04-11 2017-07-21 深圳瀚星翔科技有限公司 电子烟烟油及其制备方法

Also Published As

Publication number Publication date
JP7258911B2 (ja) 2023-04-17
RU2020136071A (ru) 2022-05-04
EP3787429A1 (en) 2021-03-10
IL305868B2 (en) 2025-03-01
JP7682942B2 (ja) 2025-05-26
NZ768771A (en) 2024-07-05
AU2022218470B2 (en) 2024-07-04
RU2020136071A3 (enExample) 2022-05-04
KR20230151065A (ko) 2023-10-31
KR102594623B1 (ko) 2023-10-25
CN112074201A (zh) 2020-12-11
JP2021523690A (ja) 2021-09-09
US20210368850A1 (en) 2021-12-02
IL305868A (en) 2023-11-01
KR20200136033A (ko) 2020-12-04
AU2019264022A1 (en) 2020-10-29
IL277973B1 (en) 2023-10-01
IL277973A (en) 2020-11-30
CA3190409A1 (en) 2019-11-07
MX2020011664A (es) 2020-12-10
IL305868B1 (en) 2024-11-01
GB201807305D0 (en) 2018-06-20
CA3099021A1 (en) 2019-11-07
JP2023085453A (ja) 2023-06-20
WO2019211629A1 (en) 2019-11-07
MY203314A (en) 2024-06-24
IL277973B2 (en) 2024-02-01
AU2022218470A1 (en) 2022-09-08

Similar Documents

Publication Publication Date Title
AU2022218470B2 (en) Vaporisable formulation
JP6731019B2 (ja) 非プロトン化型およびプロトン化型のニコチンを含む溶液
JP6450002B2 (ja) ニコチン溶液を含む容器
ES2984536T3 (es) Formulación aerosolizable
UA127838C2 (uk) Склад, здатний до утворення аерозолю
US20250127218A1 (en) Aerosol provision system
BR112021008561A2 (pt) formulação aerossolizada, processo para formar um aerossol, sistema eletrônico de fornecimento de aerossol e processo para melhorar a distribuição de sabor a uma formulaç ão aerossolizada
BR112021008543A2 (pt) formulação aerossolizável, processo para formar um aerossol, formulação aerossolizável contida, sistema eletrônico de provisão de aerossol, processo para melhorar as propriedades sensoriais de uma formulação de nicotina aerossolizada, uso de um ou mais ácidos para melhorar as propriedades sensoriais de uma formulação de nicotina aerossolizada
BR112021008586A2 (pt) formulação aerossolizável, processo para formar uma formulação aerossolizável, formulação aerossolizável contida e sistema eletrônico de provisão de aerossol
JP2021500890A (ja) 加香された気化性配合物
JP7755751B2 (ja) エアロゾル化可能な材料
RU2772501C2 (ru) Испаряемый состав
KR20260062994A (ko) 양성자화되지 않은 형태 및 양성자화된 형태의 니코틴을 포함하는 용액

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL